Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for Rocket Pharmaceuticals Inc Common Stock (RCKT).
- Disclosed ownership: 7.9%.
- Date of event: 31 Dec 2025.
VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Rocket Pharmaceuticals Inc Common Stock (RCKT)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Symbol
- RCKT
- Shares outstanding
- 108,294,335 shares
- Disclosed Ownership
- 8,544,423 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Jan 2026, 14:46:14 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 27 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 7.9% ownership in Rocket Pharmaceuticals Inc Common Stock (RCKT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Jan 2026, 14:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 7.9% | 8,544,423 | 0 | 596,350 | Ashley Grim | Head of Global Fund Administration |